市場調査レポート

商品コード

1596822

細胞分析の市場規模・シェア・成長分析 (製品・サービス別、手法別、プロセス別、エンドユーザー別、地域別)：産業予測 (2024～2031年)

Cell Analysis Market Size, Share, Growth Analysis, By Product & Service, By Technique, By Process, By End User By Region -Industry Forecast 2024-2031.

出版日: 2024年11月19日
発行: SkyQuest
ページ情報: 英文 209 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 778,146円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 910,284円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,042,422円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.82円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の細胞分析の市場規模は、2022年に195億米ドルと評価され、2023年の216億1,000万米ドルから2031年には490億8,000万米ドルに拡大し、予測期間 (2024～2031年) に10.80%のCAGRで成長する見通しです。

細胞分析市場は、慢性疾患の罹患率の上昇、細胞分析技術の継続的な進歩、創薬活動の活発化などを背景に、2024年に大きく成長する見通しです。心血管疾患・がん・自己免疫疾患・関節リウマチなどの慢性疾患が流行するにつれて、効果的な細胞分析ツールに対する需要が急増すると予想されます。これらのツールは、慢性疾患と闘う患者の治療オプションの可能性を特定する上で極めて重要です。がん診断への注目の高まりはこの動向を浮き彫りにしており、Serum Detectのような組織は、2024年3月に米国がん研究協会 (AACR) から指名されたT細胞検査のような革新的なアプローチで評価を得ています。このようなイニシアチブは、市場拡大に不可欠な細胞診断能力の強化に対する医療業界のコミットメントを反映しています。さらに、細胞分析における受動的バイオ分離システムやその他の先端技術の開発は、結果の精度と効率を大幅に改善し、市場の潜在力をさらに高めています。情勢が進化するにつれ、最先端技術の統合と慢性疾患に対するより深い理解が、細胞分析分野の成長とイノベーションを牽引し続けると思われます。

北米 (製品・サービス別、手法別、プロセス別、エンドユーザー別)
- 米国
- カナダ
欧州 (製品・サービス別、手法別、プロセス別、エンドユーザー別)
- 英国
- ドイツ
- スペイン
- フランス
- イタリア
- その他欧州
アジア太平洋 (製品・サービス別、手法別、プロセス別、エンドユーザー別)
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ (製品・サービス別、手法別、プロセス別、エンドユーザー別)
- ブラジル
- その他ラテンアメリカ
中東・アフリカ (製品・サービス別、手法別、プロセス別、エンドユーザー別)
- 湾岸協力会議 (GCC) 諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング (2023年)
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析 (2023年)
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の対前年成長率 (YoY) の比較 (2021～2023年)

主要企業プロファイル

Thermo Fisher Scientific Inc.
Danaher
Becton, Dickinson and Company (BD)
General Electric
Merck KGAA
Agilent Technologies, Inc.
Bio-rad Laboratories, Inc.
Standard Biotools
Miltenyi Biotec
Olympus Corporation
Biostatus Limited
Nanocellect Biomedical
Creative Bioarray
Meiji Techno
Promega Corporation
Perkinelmer U.S. LLC
Tecan Trading AG
Carl Zeiss AG
Sysmex
Qiagen

結論と推奨事項

Product Code: SQMIG35H2316

Global Cell Analysis Market size was valued at USD 19.5 billion in 2022 and is poised to grow from USD 21.61 billion in 2023 to USD 49.08 billion by 2031, growing at a CAGR of 10.80% during the forecast period (2024-2031).

The cell analysis market is poised for significant growth in 2024, driven by the rising incidence of chronic diseases, continuous advancements in cellular analysis technologies, and an uptick in drug discovery activities. As chronic conditions such as cardiovascular diseases, cancers, autoimmune disorders, and rheumatoid arthritis become more prevalent, the demand for effective cellular analysis tools is expected to surge. These tools are critical in identifying potential therapeutic options for patients battling chronic illnesses. The increasing focus on cancer diagnostics highlights this trend, with organizations like Serum Detect gaining recognition for innovative approaches, such as their T-cellular testing nominated by the American Association for Cancer Research (AACR) in March 2024. Such initiatives reflect the healthcare industry's commitment to enhancing cellular diagnostic capabilities, which is essential for market expansion. Additionally, the development of passive bioseparation systems and other advanced technologies in cell analysis has significantly improved both the accuracy and efficiency of results, further bolstering market potential. As the landscape evolves, the integration of cutting-edge technologies and a deeper understanding of chronic diseases will continue to drive growth and innovation within the cell analysis sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Analysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Analysis Market Segmental Analysis

Global Cell Analysis Market is segmented into Product & Service, Technique, Process, end user, and region. By Product & Service, the market is classified into Reagents & Consumables, Instruments, Accessories, Software, and Services. Depending on the Technique, it is categorized into Flow Cytometry, PCR, Cell Microarrays, Microscopy, Spectrophotometry, High-Content Screening, and Other Techniques. By Process, the market is classified into Cell Identification, Cell Viability, Cell Signaling Pathway/Signal Transduction, Cell Proliferation, Cell Counting and Quality Control, Cell Interaction, Cell Structure Study, Target Identification and Validation, and Single-Cell Analysis. According to End User, the market is divided into Pharmaceutical and Biotechnology Companies, Hospitals and Clinical Testing Laboratories, Academic and Research Institutes, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Cell Analysis Market

The Global Cell Analysis market is being significantly propelled by the rising demand for personalized medicine. Advances in molecular biology and genomics are making it possible to tailor treatments to individual patients based on their unique genetic profiles. This shift towards customization in therapeutic approaches is revolutionizing healthcare, as it enhances the understanding of disease mechanisms at the cellular level. Consequently, biotech innovations facilitate improved diagnostics and enable targeted therapies, which contribute to the overall growth of the cell analysis market. This growing trend emphasizes the importance of developing effective and individualized treatment options, further driving market expansion.

Restraints in the Global Cell Analysis Market

One significant constraint facing the global cell analysis market is the elevated costs linked to advanced equipment and technology. Essential tools such as flow cytometers, cell counters, and imaging systems necessitate substantial initial investments, which can be a barrier for smaller laboratories and research institutions. Additionally, the ongoing expenses related to the maintenance and upgrading of these sophisticated devices further impede market expansion. As a result, the financial burden associated with acquiring and sustaining high-quality cell analysis equipment may limit accessibility and capabilities, posing challenges to the overall growth and development of the sector.

Market Trends of the Global Cell Analysis Market

The Global Cell Analysis market is experiencing a significant shift driven by rapid technological advancements in single-cell analysis. As researchers increasingly adopt methods like single-cell RNA sequencing and high-throughput single-cell assays, this trend is unlocking unprecedented insights into cellular processes, differentiation, and disease mechanisms that were previously unattainable with bulk analysis techniques. This innovation is particularly impactful in fields such as cancer research, immunology, and regenerative medicine, fostering enhanced understanding and treatment strategies. As these technologies become more accessible and integrated into standard research and clinical applications, the demand for sophisticated cell analysis tools is projected to continue growing, shaping the market's trajectory through 2024 and beyond.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Case Study Analysis
Customer & Buying Criteria Analysis
PESTEL Analysis
Startup Analysis
Market Attractiveness Index
Pricing Analysis

Global Cell Analysis Market Size by Product & Service & CAGR (2024-2031)

Market Overview
Reagents & Consumables
Instruments
Accessories
Software
Services

Global Cell Analysis Market Size by Technique & CAGR (2024-2031)

Market Overview
Flow Cytometry
PCR
Cell Microarrays
Microscopy
Spectrophotometry
High-Content Screening
Other Techniques

Global Cell Analysis Market Size by Process & CAGR (2024-2031)

Market Overview
Cell Identification
Cell Viability
Cell Signaling Pathway/Signal Transduction
Cell Proliferation
Cell Counting and Quality Control
Cell Interaction
Cell Structure Study
Target Identification and Validation
Single-Cell Analysis

Global Cell Analysis Market Size by End User & CAGR (2024-2031)

Market Overview
Pharmaceutical And Biotechnology Companies
Hospitals And Clinical Testing Laboratories
Academic And Research Institutes
Other End Users

Global Cell Analysis Market Size & CAGR (2024-2031)

North America, (Product & Service, Technique, Process, End User)
- US
- Canada
Europe, (Product & Service, Technique, Process, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Product & Service, Technique, Process, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Product & Service, Technique, Process, End User)
- Brazil
- Rest of Latin America
Middle East & Africa, (Product & Service, Technique, Process, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
General Electric
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGAA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Standard Biotools
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biostatus Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nanocellect Biomedical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Bioarray
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meiji Techno
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Perkinelmer U.S. LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tecan Trading AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Carl Zeiss AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

細胞分析の市場規模・シェア・成長分析 (製品・サービス別、手法別、プロセス別、エンドユーザー別、地域別)：産業予測 (2024～2031年)

Cell Analysis Market Size, Share, Growth Analysis, By Product & Service, By Technique, By Process, By End User By Region -Industry Forecast 2024-2031.

目次

イントロダクション

分析手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

世界の細胞分析の市場規模 (製品・サービス別)・CAGR (2024～2031年)

世界の細胞分析の市場規模 (手法別)・CAGR (2024～2031年)

世界の細胞分析の市場規模 (プロセス別)・CAGR (2024～2031年)

世界の細胞分析の市場規模 (エンドユーザー別)・CAGR (2024～2031年)

世界の細胞分析の市場規模・CAGR (2024～2031年)